(Reuters) – Moderna Inc said on Thursday it was actively preparing to launch its coronavirus vaccine candidate, which is currently being tested in a large human trial.
Moderna has finished enrolling participants for a 30,000-volunteer study that is testing whether the vaccine can help prevent COVID-19.
(Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty)
